Brief: Gri Bio Granted Japan Patent For NKT Cell Modulators
30/09/2024 13:46
Sept 30 (Reuters) - GRI Bio Inc GRI.O :
* GRI BIO GRANTED JAPAN PATENT FOR PROPRIETARY NATURAL
KILLER T
(NKT) CELL MODULATORS FOR PREVENTION AND TREATMENT OF
INFLAMMATORY CONDITIONS
* GRI BIO INC - RECEIVES PATENT GRANT NOTICE FROM JAPAN
PATENT
OFFICE
* GRI BIO INC - INTERIM DATA EXPECTED IN Q4 2024, TOPLINE
DATA IN
Q1 2025
Source text for Eikon: urn:newsml:reuters.com:*:nGNX4fwlPY
Further company coverage: GRI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on GRI Bio
See all newsGRI Bio Inc reports results for the quarter ended June 30 - Earnings Summary
GRI Bio Inc expected to post a loss of $1.19 a share - Earnings Preview
Brief: Gri Bio Secures FDA Orphan Drug Designation For Gri-0621 (Tazarotene) In Idiopathic Pulmonary Fibrosis
GRI Bio Q1 net loss narrows on lower R&D expenses
GRI Bio raises $14.5 mln to fund operations into Q1 2027